AG
RPRX icon

AmeriFlex Group’s Royalty Pharma RPRX Stock Holding History

AmeriFlex Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Buy
462
+122
+36% +$6.35K 0.01% 648
2026
Q1 		$16.3K Hold
340
– – 0.01% 648
2025
Q4 		$13.1K Sell
340
-340
-50% -$13K 0.01% 675
2025
Q3 		$24K Buy
680
+340
+100% +$12.3K 0.01% 614
2025
Q2 		$12K Hold
340
– – 0.01% 670
2025
Q1 		$10.6K Hold
340
– – ﹤0.01% 835
2024
Q4 		$10.7K Buy
+340
New +$9.02K ﹤0.01% 758

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AmeriFlex Group's RPRX Position: Q2 2026 in Review

AmeriFlex Group increased its Royalty Pharma (RPRX) stake by 36% in Q2 2026, buying an estimated $6.35K and bringing the position to 462 shares worth $25.9K. The position accounts for 0.01% of the portfolio, ranked #648.

AmeriFlex Group first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • AmeriFlex Group held 462 shares of Royalty Pharma worth $25.9K as of Q2 2026.
  • AmeriFlex Group bought 122 Royalty Pharma shares in Q2 2026, an estimated $6.35K.
  • Royalty Pharma made up 0.01% of AmeriFlex Group's portfolio in Q2 2026, its #648 holding.
  • AmeriFlex Group first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.